These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Supuran CT Curr Pharm Des; 2010; 16(29):3233-45. PubMed ID: 20819070 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds. Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009 [TBL] [Abstract][Full Text] [Related]
8. An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C. Mujumdar P; Teruya K; Tonissen KF; Vullo D; Supuran CT; Peat TS; Poulsen SA J Med Chem; 2016 Jun; 59(11):5462-70. PubMed ID: 27172398 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Carta F; Maresca A; Covarrubias AS; Mowbray SL; Jones TA; Supuran CT Bioorg Med Chem Lett; 2009 Dec; 19(23):6649-54. PubMed ID: 19846301 [TBL] [Abstract][Full Text] [Related]
10. Natural products that inhibit carbonic anhydrase. Poulsen SA; Davis RA Subcell Biochem; 2014; 75():325-47. PubMed ID: 24146386 [TBL] [Abstract][Full Text] [Related]
11. State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes. Bozdag M; Altamimi ASA; Vullo D; Supuran CT; Carta F Curr Med Chem; 2019; 26(15):2558-2573. PubMed ID: 29932025 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Supuran CT Future Med Chem; 2011 Jul; 3(9):1165-80. PubMed ID: 21806379 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII. Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787 [TBL] [Abstract][Full Text] [Related]
16. Sulfonamide Inhibition Studies of a New β-Carbonic Anhydrase from the Pathogenic Protozoan Bua S; Haapanen S; Kuuslahti M; Parkkila S; Supuran CT Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544802 [TBL] [Abstract][Full Text] [Related]
17. Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors. Rogato A; Del Prete S; Nocentini A; Carginale V; Supuran CT; Capasso C J Enzyme Inhib Med Chem; 2019 Dec; 34(1):510-518. PubMed ID: 30688123 [TBL] [Abstract][Full Text] [Related]
18. 2-Amino-3-cyanopyridine derivatives as carbonic anhydrase inhibitors. Ayvaz S; Çankaya M; Atasever A; Altuntas A J Enzyme Inhib Med Chem; 2013 Apr; 28(2):305-10. PubMed ID: 22141460 [TBL] [Abstract][Full Text] [Related]
19. Pharmacophores Modeling in Terms of Prediction of Theoretical Physicochemical Properties and Verification by EXPERIMENTAL correlations of Carbacylamidophosphates (CAPh) and Sulfanylamidophosphates (SAPh) Tested as New Carbonic Anhydrase Inhibitors. Amirkhanov V; Rauf A; Hadda TB; Ovchynnikov V; Trush V; Saleem M; Raza M; Rehman T; Zgou H; Shaheen U; Farghaly TA Mini Rev Med Chem; 2019; 19(12):1015-1027. PubMed ID: 30806314 [TBL] [Abstract][Full Text] [Related]
20. Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Nishimori I; Vullo D; Minakuchi T; Scozzafava A; Capasso C; Supuran CT Bioorg Med Chem; 2014 Jun; 22(11):2939-46. PubMed ID: 24792813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]